Show simple item record

dc.contributor.authorArco Torres, Ana
dc.contributor.authorCortés Martín, Jonathan 
dc.contributor.authorTovar Gálvez, María Isabel 
dc.contributor.authorMontiel Troya, María 
dc.contributor.authorRiquelme Gallego, Blanca 
dc.contributor.authorRodríguez Blanque, Raquel
dc.date.accessioned2021-11-25T09:30:32Z
dc.date.available2021-11-25T09:30:32Z
dc.date.issued2021-10-24
dc.identifier.citationArco-Torres, A.; Cortés-Martín, J.; Tovar-Gálvez, M.I.; Montiel-Troya, M.; Riquelme-Gallego, B.; Rodríguez-Blanque, R. Pharmacological Treatments against COVID-19 in Pregnant Women. J. Clin. Med. 2021, 10, 4896. [https:// doi.org/10.3390/jcm10214896]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/71748
dc.description.abstractThe recent respiratory virus known as SARS-CoV-2 has caused millions of deaths world-wide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiological conditions that expose the pregnant woman and the foetus to greater risk. Pregnant women are often excluded from trials due to possible risk of toxicity or side effects, resulting in a lack of knowledge about the use of drugs and treatments during pregnancy. The main objective of this review was to compile existing knowledge about currently available drug treatments for COVID-19 in pregnant women. The review report met the criteria of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) review protocol and was registered with the registration number CRD42021251036. The electronic databases searched were Scopus, PubMed, CINAHL and SciELO. Finally, 22 articles were included, resulting in an analysis of drugs with an acceptable safety profile in the treatment of pregnant women with COVID-19.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectSARS-CoV-2es_ES
dc.subjectCOVID-19es_ES
dc.subjectVirus es_ES
dc.subjectPregnant womanes_ES
dc.subjectFoetuses_ES
dc.subjectPharmacological treatmentes_ES
dc.titlePharmacological Treatments against COVID-19 in Pregnant Womenes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.3390/jcm10214896
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España